Comments to the NMPA on Measures for the Implementation of the Early Resolution Mechanism for Drug Patent Disputes (Trial)

2020-10-25 | Beijing, Shanghai

The Legal and IPR WGs submitted revision suggestions on issues including patent registration for drugs and litigation time limit.